Conditions: Mild Cognitive Impairment
Keywords: Mild Cognitive Impairment
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 145

Brief summary:
This is a multi-center, open-label study of 28 weeks duration in subjects with Mild Cognitive Impairment who have completed the double-blind study (E2020-A001-412).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Aricept (donepezil hydrochloride) intervention 2: placebo
Intervention descriptions: intervention 1: 5 mg or 10 mg of donepezil hydrochloride (Aricept) taken orally once a day. intervention 2: None

Protocol document: